Contact
Please use this form to send email to PR contact of this press release:
NeuroGenesis Announces Positive Phase 2 Extension Study Results of NG01 Cell Therapy in Progressive Multiple Sclerosis
TO:
Lisa Miller
Lisa T Miller, Healthcare Strategist
+1 786-214-9024